# MetfOrmin BenefIts Lower Extremities With Intermittent Claudication

Study · id `cardio:ct-nct05132439` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05132439](<https://clinicaltrials.gov/study/NCT05132439>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05132439

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 200 participants.

## Technical summary

Registry record NCT05132439. Randomized; quadruple masking; primary purpose treatment. Start 2022-03-01 (actual); primary completion 2027-02-28 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT05132439, source copy `cardio:ctgov-nct05132439-2026-04-21`, retrieved 2026-10-31)
- Started: 2022-03-01 (actual) (ClinicalTrials.gov record NCT05132439, source copy `cardio:ctgov-nct05132439-2026-04-21`, retrieved 2026-10-31)
- Primary completion: 2027-02-28 (anticipated) (ClinicalTrials.gov record NCT05132439, source copy `cardio:ctgov-nct05132439-2026-04-21`, retrieved 2026-10-31)
- Completion: 2032-02-28 (anticipated) (ClinicalTrials.gov record NCT05132439, source copy `cardio:ctgov-nct05132439-2026-04-21`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT05132439, source copy `cardio:ctgov-nct05132439-2026-04-21`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05132439-2026-04-21`, retrieved 2026-10-31)

## The registry's words

- Brief title: MetfOrmin BenefIts Lower Extremities With Intermittent Claudication
- Acronym: MOBILE IC
- Condition: Intermittent Claudication
- Intervention (Drug): Metformin ER
- Intervention (Drug): placebo
- Lead sponsor: VA Office of Research and Development
- Lead sponsor class: FED
- Collaborator: University of Pittsburgh
- Collaborator class: OTHER
- Collaborator: Northwestern University
- Collaborator class: OTHER
- Collaborator: San Francisco Veterans Affairs Medical Center
- Collaborator class: FED

## Connected pages

- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: VA Office of Research and Development (`cardio:org-va-office-of-research-and-development`)
- Registry lists this organization as a collaborator: University of Pittsburgh (`cardio:org-university-of-pittsburgh`)
- Registry lists this organization as a collaborator: Northwestern University (`cardio:org-northwestern-university`)

## Provenance

Content hash: eabbe38775b79fe5035e7776c67f6e702ab654032dc0b6277019fb91b542d047
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
